Reduction of Intracellular pH Inhibits Constitutive Expression of Cyclooxygenase-2 in Human Colon Cancer Cells

Journal of Cellular Physiology

Volumn 198, Issue 2, 2004, Pages 295-301

  Pirkebner, Daniela ^a   Fuetsch, Michaela ^a   Wittmann, Walter ^a   Weiss, Helmut ^a   Haller, Thomas ^b   Schramek, Herbert ^b   Margreiter, Raimund ^a   Amberger, Albert ^a  

^a TYROLEAN CANCER RESEARCH INSTITUTE   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; CYCLOOXYGENASE 2; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PH; CELL STRAIN CACO 2; COLON CANCER; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CACO-2 CELLS; COLONIC NEOPLASMS; CYCLOHEXIMIDE; CYCLOOXYGENASE 2; ENZYME INHIBITORS; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOBLOTTING; INTRACELLULAR FLUID; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 1642579727     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10408     Document Type: Article

References (35)

1. Bierman AJ, Cragoe EJ, Jr., de Laat SW, Moolenaar WH. 1988. Bicarbonate determines cytoplasmic pH and suppresses mitogen-induced alkalinization in fibroblastic cells. J Biol Chem 263:15253-15256.
2. Bischof G, Cosentini E, Hamilton G, Riegler M, Zacherl J, Teleky B, Feil W, Schiessel R, Machen TE, Wenzl E. 1996. Effects of extracellular pH on intracellular pH-regulation and growth in a human colon carcinoma cell-line. Biochim. Biophys Acta 1282:131-139.
3. Bright GR, Fisher GW, Rogowska J, Taylor DL. 1987. Fluorescence ratio imaging microscopy: Temporal and spatial measurements of cytoplasmic pH. J Cell Biol 104:1019-1033.
4. Busa WB, Nuccitelli R. 1984. Metabolic regulation via intracellular pH. Am J Physiol 246:R409-R438.
5. Dixon DA, Tolley ND, King PH, Nabors LB, McIntyre TM, Zimmerman GA, Prescott SM. 2001. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest 108:1657-1665.
6. DuBois RN, Radhika A, Reddy BS, Entingh AJ. 1996. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110:1259-1262.
7. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. 1994. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183-1188.
8. Gekle M, Schwerdt G, Freudinger R, Mildenberger S, Wilflingseder D, Pollack V, Dander M, Schramek H. 2000. Ochratoxin A induces JNK activation and apoptosis in MDCK-C7 cells at nanomolar concentrations. J Pharmacol Exp Ther 293:837-844.
9. Gillies RJ, Martinez-Zaguilan R, Martinez GM, Serrano R, Perona R. 1990. Tumorigenic 3T3 cells maintain an alkaline intracellular pH under physiological conditions. Proc Natl Acad Sci USA 87:7414-7418.
10. + exchange and growth factor-induced cytosolic pH changes. Role in cellular proliferation. Biochim. Biophys Acta 988:73-97.
11. Gross E, Kurtz I. 2002. Structural determinants and significance of regulation of electrogenic Na(+)-HCO(3)(-) cotransporter stoichiometry. Am J Physiol Renal Physiol 283:F876-F887.
12. Guan Z, Buckman SY, Pentland AP, Templeton DJ, Morrison AR. 1998. Induction of cyclooxygenase-2 by the activated MEKK1 → SEK1/MKK4 → p38 mitogen-activated protein kinase pathway. J Biol Chem 273:12901-12908.
13. Jacoby RF, Seibert K, Cole CE, Kelloff G, Lubet RA. 2000. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res 60:5040-5044.
14. 3 exchange in NIH-3T3 fibroblasts. J Biol Chem 269:4116-4124.
15. Lang F, Busch GL, Ritter M, Volkl H, Waldegger S, Gulbins E, Haussinger D. 1998. Functional significance of cell volume regulatory mechanisms. Physiol Rev 78:247-306.
16. McLean LA, Roscoe J, Jorgensen NK, Gorin FA, Cala PM. 2000. Malignant gliomas display altered pH regulation by NHE1 compared with nontransformed astrocytes. Am J Physiol Cell Physiol 278:C676-C688.
17. Moolenaar WH. 1986. Effects of growth factors on intracellular pH regulation. Annu Rev Physiol 48:363-376.
18. Musgrove E, Seaman M, Hedley D. 1987. Relationship between cytoplasmic pH and proliferation during exponential growth and cellular quiescence. Exp Cell Res 172:65-75.
19. O'Neill GP, Ford-Hutchinson AW. 1993. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 330:156-160.
20. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM. 1996. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87:803-809.
21. Oshima M, Murai N, Kargman S, Arguello M, Luk P, Kwong E, Taketo MM, Evans JF. 2001. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res 61:1733-1740.
22. Perona R, Serrano R. 1988. Increased pH and tumorigenicity of fibroblasts expressing a yeast proton pump. Nature 334:438-440.
23. Pouyssegur J, Franchi A, L'Allemain G, Paris S. 1985. Cytoplasmic pH, a key determinant of growth factor-induced DNA synthesis in quiescent fibroblasts. FEBS Lett 190:115-119.
24. Puceat M. 1999. pHi regulatory ion transporters: An update on structure, regulation, and cell function. Cell Mol Life Sci 55:1216-1229.
25. + exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J 14:2185-2197.
26. Rich IN, Worthington-White D, Garden OA, Musk P. 2000. Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na(+)/H(+) exchanger. Blood 95:1427-1434.
27. Seksek O, Bolard J. 1996. Nuclear pH gradient in mammalian cells revealed by laser microspectrofluorimetry. J Cell Sci 109(Pt 1):257-262.
28. Shao J, Sheng H, Inoue H, Morrow JD, DuBois RN. 2000. Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells. J Biol Chem 275:33951-33956.
29. Smith WL, Dewitt DL. 1996. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol 62:167-215.
30. Smith WL, Langenbach R. 2001. Why there are two cyclooxygenase isozymes. J Clin Invest 107:1491-1495.
31. Subbaramaiah K, Dannenberg AJ. 2003. Cyclooxygenase 2: A molecular target for cancer prevention and treatment. Trends Pharmacol Sci 24:96-102.
32. Vaupel P, Kallinowski F, Okunieff P. 1989. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 49:6449-6465.
33. Weinlich M, Theiss C, Lin CT, Kinne RK. 1998. BCECF in single cultured cells: Inhomogeneous distribution but homogeneous response. J Exp Biol 201(Pt 1):57-62.
34. Weiss H, Amberger A, Widschwendter M, Margreiter R, Ofner D, Dietl P. 2001. Inhibition of store-operated calcium entry contributes to the anti-proliferative effect of non-steroidal anti-inflammatory drugs in human colon cancer cells. Int J Cancer 92:877-882.
35. Williams CS, Luongo C, Radhika A, Zhang T, Lamps LW, Nanney LB, Beauchamp RD, DuBois RN, 1996. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology 111:1134-1140.